Rising insurance premiums, surprise medical bills,
unfair drug price hikes — if you read the headlines, our collective anxiety over health costs is well - founded.
That defensive position came under attack in 2015 as political rhetoric from both sides zeroed in on perceived
unfair drug pricing.
Not exact matches
The UK's competition watchdog has accused two drugmakers of charging «excessive and
unfair»
prices for an anti-epilepsy
drug in Britain.
This prevented developing countries from producing generic versions of patented
drugs, notably treatments for HIV / AIDS and malaria, which they maintained were being sold at
unfair prices.